Genome Medical picks up $60M Series C

Genome Medical has raised $60 million in a round led by Casdin Capital. Founded in 2016, the Bay Area-based company is the developer of a telehealth platform focused on genomic medicine that provides clinical assessments, test recommendations, personalized care plans and more. Genome Medical has also announced its plan to acquire GeneMatters, a provider of telehealth-based genetic counseling and software solutions.

Select Additional Investors

Amgen Ventures, Avestria Ventures, Dreamers VC, Echo Health Ventures, Flywheel Ventures, GV, Illumina Ventures

View round

News & Analysis

Related content